May 21, 2018 / 6:28 AM / 3 months ago

BRIEF-Oncodesign Announces Interim Results Of Clinical Study With First Radiotracer

May 21 (Reuters) - ONCODESIGN SA:

* ANNOUNCED ON FRIDAY PUBLICATION OF ABSTRACT WITH INTERIM RESULTS OF FIRST 12 PATIENTS PARTICIPATING IN CLINICAL STUDY WITH ITS FIRST RADIOTRACER

* IN FIRST STAGE OF STUDY, 8 PATIENTS WITH EGFR MUTATIONS RECEIVED INJECTION OF RADIOTRACER

* RESULTS SHOWED THAT RADIOTRACER DID REACH AND BIND TO ITS TARGET, WHETHER A PRIMARY OR METASTATIC TUMOR

* SIGNAL REDUCTION AFTER ONE WEEK’S TREATMENT CONFIRMED THE PRESENCE OF THE THERAPEUTIC MOLECULE WITHIN THE TUMOR

* IN TWO PATIENTS, THE RADIOTRACER ALSO ALERTED THE ONCOLOGIST TO PRESENCE OF BRAIN METASTASES, WHICH HAD GONE UNNOTICED UNTIL THEN

* RESULTS PRESENTED AT ASCO (AMERICAN SOCIETY OF CLINICAL ONCOLOGY) ALSO INCLUDE FIRST 4 PATIENTS RECRUITED IN STUDY’S SECOND STAGE

* THESE INITIAL RESULTS IN PATIENTS WITH NO EGFR MUTATION VALIDATE SPECIFICITY OF RADIOTRACER

Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below